Items where contributor is "Le Rütte, Epke"

Borlase, A. and Le Rütte, E. A. and Castaño, S. and Blok, D. J. and Toor, J. and Giardina, F. and Davis, E. L. and Modelling Consortium, N. T. D.. (2022) Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study. Lancet Glob Health, 10 (11). e1600-e1611.

Kelly, S. L. and Le Rütte, E. A. and Richter, M. and Penny, M. A. and Shattock, A. J.. (2022) COVID-19 vaccine booster strategies in light of emerging viral variants: frequency, timing, and target groups. Infect Dis Ther, 11 (5). pp. 2045-2061.

Le Rütte, E. A. and Shattock, A. J. and Chitnis, N. and Kelly, S. L. and Penny, M. A.. (2022) Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden. Commun Med (Lond), 2. p. 93.

Coffeng, L. E. and Le Rutte, E. A. and Munoz, J. and Adams, E. and de Vlas, S. J.. (2021) Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study. Clinical infectious diseases, 72 (Suppl. 3). S180-S187.

Kaye, P. M. and Mohan, S. and Mantel, C. and Malhame, M. and Revill, P. and Le Rutte, E. and Parkash, V. and Layton, A. M. and Lacey, C. J. N. and Malvolti, S.. (2021) Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert Rev Vaccines, 20 (11). pp. 1419-1430.

Le Rutte, E. A. and Coffeng, L. E. and Munoz, J. and de Vlas, S. J.. (2021) Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India. Trans R Soc Trop Med Hyg, 115 (3). pp. 229-235.

Malvolti, S. and Malhame, M. and Mantel, C. F. and Le Rütte, E. A. and Kaye, P. M.. (2021) Human leishmaniasis vaccines: use cases, target population and potential global demand. PLoS Negl Trop Dis, 15 (9). e0009742.

Shattock, A. J. and Le Rütte, E. A. and Dünner, R. P. and Sen, S. and Kelly, S. L. and Chitnis, N. and Penny, M. A.. (2021) Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland. Epidemics, 38. p. 100535.

Toor, J. and Adams, E. R. and Aliee, M. and Amoah, B. and Anderson, R. M. and Ayabina, D. and Bailey, R. and Basanez, M. G. and Blok, D. J. and Blumberg, S. and Borlase, A. and Rivera, R. C. and Castaño, M. S. and Chitnis, N. and Coffeng, L. E. and Crump, R. E. and Das, A. and Davis, C. N. and Davis, E. L. and Deiner, M. S. and Diggle, P. J. and Fronterre, C. and Giardina, F. and Giorgi, E. and Graham, M. and Hamley, J. I. D. and Huang, C. I. and Kura, K. and Lietman, T. M. and Lucas, T. C. D. and Malizia, V. and Medley, G. F. and Meeyai, A. and Michael, E. and Porco, T. C. and Prada, J. M. and Rock, K. S. and Le Rutte, E. A. and Smith, M. E. and Spencer, S. E. F. and Stolk, W. A. and Touloupou, P. and Vasconcelos, A. and Vegvari, C. and de Vlas, S. J. and Walker, M. and Hollingsworth, T. D.. (2021) Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation. Clinical infectious diseases, 72 (8). pp. 1463-1466.

Toor, J. and Hamley, J. I. D. and Fronterre, C. and Castaño, M. S. and CHapman, L. A. C. and Coffeng, L. E. and Giardina, F. and Lietman, T. M. and Michael, E. and Pinsent, A. and Le Rutte, E. A. and Hollingsworth, T. D.. (2021) Strengthening data collection for neglected tropical diseases: what data are needed for models to better inform tailored intervention programmes? PLoS Negl Trop Dis, 15 (5). e0009351.